Current standard immunotherapy with medications such as keytruda, opdivo or yervoy results vary depending on many factors with a 24 month survival rate of 53% in melanoma, a better responding cancer, with occasional cures. These therapies are expensive, have side effects and still are lacking in results. We now have made a quantum leap in cancer treatment by adding ablation with vaccine adjuvants, completely blowing away the results of standard immunotherapy. https://williamscancerinstitute.com
0:32
Current standard immunotherapy with medications such as keytruda, opdivo or yervoy results vary depending on many factors with a 24 month survival rate of 53% in melanoma, a better responding cancer, with occasional cures. These therapies are expensive, have side effects and still are lacking in results. We now have made a quantum leap in cancer treatment by adding ablation with vaccine adjuvants, completely blowing away the results of standard immunotherapy. https://williamscancerinstitute.com
411 viewsApr 5, 2023
FacebookWilliams Cancer Institute
Missed our mesothelioma immunotherapy webinar? Download a recording to learn about Opdivo and Yervoy! Discover the benefits, differences between other immunotherapies & who is eligible. | The Mesothelioma Center
0:38
Missed our mesothelioma immunotherapy webinar? Download a recording to learn about Opdivo and Yervoy! Discover the benefits, differences between other immunotherapies & who is eligible. | The Mesothelioma Center
303.2K viewsDec 22, 2022
FacebookThe Mesothelioma Center
Opdivo Yervoy TV Spot, 'Combination Immunotherapy Treatment'
1:30
Opdivo Yervoy TV Spot, 'Combination Immunotherapy Treatment'
Aug 31, 2020
iSpot.tv
New Treatment, Real Progress After 2 years on immunotherapy (Opdivo Yervoy), my tumor markers (CEA) spiked to 106. PET CT revealed a sternum mass and tumor growth in my abdomen. I underwent 5 radiation sessions targeting the sternum and switched to a new drug, “Lonsurf”. 4 months in, latest CT scans show improvement, and my tumor markers dropped from 106 to 35 (normal is 0-5). Monthly Avastin infusions help too. Feeling good overall—with some fatigue and nausea—but thankful for my incredible wif
1:45
New Treatment, Real Progress After 2 years on immunotherapy (Opdivo Yervoy), my tumor markers (CEA) spiked to 106. PET CT revealed a sternum mass and tumor growth in my abdomen. I underwent 5 radiation sessions targeting the sternum and switched to a new drug, “Lonsurf”. 4 months in, latest CT scans show improvement, and my tumor markers dropped from 106 to 35 (normal is 0-5). Monthly Avastin infusions help too. Feeling good overall—with some fatigue and nausea—but thankful for my incredible wif
1.3K views7 months ago
FacebookCarlos Lorenzo
Bristol Myers: FDA approves Opdivo Yervoy combination
Bristol Myers: FDA approves Opdivo Yervoy combination
Apr 9, 2025
marketscreener.com
Join us on August 17 to learn about Opdivo and Yervoy! Discover immunotherapy benefits, success rates and more. | The Mesothelioma Center
0:34
Join us on August 17 to learn about Opdivo and Yervoy! Discover immunotherapy benefits, success rates and more. | The Mesothelioma Center
146 viewsAug 3, 2021
FacebookThe Mesothelioma Center
Opdivo Yervoy TV Spot, 'A Chance for More Horizons'
Opdivo Yervoy TV Spot, 'A Chance for More Horizons'
Jan 14, 2021
iSpot.tv
0:46
Opdivo Qvantig: Revolutionizing Melanoma Treatment for Teens & Adults
656 views11 months ago
YouTubeRx Explained
FDA Approves Bristol Myers Squibb's Opdivo Plus Yervoy to Treat Some Carcinomas
Apr 11, 2025
marketscreener.com
2:16
Cryoablation combined with immunotherapy, Yervoy and Opdivo significantly enhances the anti-cancer immune response over standard immunotherapy. | Williams Cancer Institute
116.3K viewsOct 26, 2016
FacebookWilliams Cancer Institute
4:04
Cancer Immunity Cycle
1 viewsJan 28, 2025
VimeoDavid Beedle
14:27
Melanoma Patient Story: Immunotherapy Treatment (Nivolumab/Opdivo) | Rich’s Story (5 of 5)
13.7K viewsMay 27, 2022
YouTubeThe Patient Story
2:16
Why Cryoablation works for Cancer
15.1K viewsOct 26, 2016
YouTubeJason Williams MD
1:15
Opdivo Yervoy TV Spot, 'A Chance for More Sparks: Live Longer'
Jan 9, 2022
iSpot.tv
1:00
Opdivo Yervoy TV Spot, 'A Chance to Live Longer'
Sep 29, 2021
iSpot.tv
47:55
Ep 65: Opdivo Qvantig (subcutaneous formulation)
59 views10 months ago
YouTubeMelanoma Matters
Expanded Approval for the PD-1 Blocking Immunotherapy Opdivo | Cancer
Mar 14, 2022
labroots.com
0:31
Opdivo Explained #cancer #immunotherapy #treatment #health #medicine
3.9K viewsFeb 9, 2025
YouTubeMedical Centric Podcast
2:47
Combination Immunotherapy Animation
13.4K viewsOct 21, 2021
YouTubeRandom42 Scientific Communication
3:01
See Full Prescribing Information for OPDIVO Qvantig™ at bit.ly/OPDIVOQvantigPI. Learn more about OPDIVO Qvantig™, a subcutaneous option approved across multiple cancer indications. | OPDIVO Qvantig™ (nivolumab hyaluronidase-nvhy)
900.6K views4 months ago
FacebookOPDIVO Qvantig™ (nivolumab hyaluronidase-…
4:00
See Full Prescribing Information for OPDIVO Qvantig at bit.ly/OPDIVOQvantigPI. Consider treating eligible patients with OPDIVO Qvantig™, a subcutaneous option available across multiple cancer indications. | OPDIVO Qvantig™ (nivolumab hyaluronidase-nvhy)
162K views9 months ago
FacebookOPDIVO Qvantig™ (nivolumab hyaluronidase-…
0:40
How Keytruda, Yervoy, and Opdivo Fight Cancer
4.5K views2 months ago
YouTube비타민 박사 염창환 TV
1:31
See Full Prescribing Information for OPDIVO Qvantig at [bit.ly/OPDIVOQvantigPI]. Infusions are not the only option when looking for a treatment. OPDIVO Qvantig is approved. Learn more about another choice that patients may have. | OPDIVO Qvantig™ (nivolumab hyaluronidase-nvhy)
1.1M views7 months ago
FacebookOPDIVO Qvantig™ (nivolumab hyaluronidase-…
1:23
New data has strengthened the growing belief that the recently FDA-approved immunotherapy combo — Opdivo and Yervoy — is the optimal first-line treatment for pleural mesothelioma. | The Mesothelioma Center
2.2K viewsJun 21, 2022
FacebookThe Mesothelioma Center
Opdivo Qvantig TV Spot, 'This Is Me'
11 months ago
iSpot.tv
Opdivo Yervoy TV Spot, 'Advanced Lung Cancer'
Oct 18, 2022
iSpot.tv
Bristol-Myers Squibb TV Spot, 'Opdivo and Yervoy: Your Search Starts Here'
Nov 25, 2024
iSpot.tv
Discover OPDIVO Qvantig | OPDIVO Qvantig™ (nivolumab + hyaluronidase-nvhy) US HCP
8 months ago
linkedin.com
0:22
The Hidden Danger Inside Immunotherapy Treatment #MelanomaAwareness #RxExplained
190 views11 months ago
YouTubeRx Explained
2:28
Opdivo is an immunotherapy that helps your immune system recognize and attack cancer cells instead of targeting the cancer directly. This approach has transformed treatment for several cancers by unlocking the body’s natural defenses. #learnontiktok #tiktoklearningcampaign #cancer #medicineexplained #cancertreatment
1.4K views4 months ago
TikTokscientistswanda
See more
Static thumbnail place holder
You may also want to search